Skip to main content
. 2021 Oct 21;50(2):457–465. doi: 10.1007/s15010-021-01719-1

Table 1.

Baseline characteristic of the study population and comparison groups

Variable Categories First wave Second wave Total p value
N = 884 (100.0%) N = 1817 (100.0%) N = 2701 (100.0%)
Sex Female 363 (41.1%) 782 (43.0%) 1145 (42.4%) 0.330
Male 521 (58.9%) 1035 (57.0%) 1556 (57.6%)
Age 18–39 71 (8.0%) 147 (8.1%) 218 (8.1%) 0.001
Grouped 40–59 190 (21.5%) 495 (27.2%) 685 (25.4%)
(years) 60–79 350 (39.6%) 724 (39.8%) 1074 (39.8%)
 ≥ 80 273 (30.9%) 451 (24.8%) 724 (26.8%)
Ethnicity White 301 (34.0%) 636 (35.0%) 937 (34.7%)  < 0.001
Asian 145 (16.4%) 346 (19.0%) 491 (18.2%)
Black 143 (16.2%) 252 (13.9%) 395 (14.6%)
Other 147 (16.6%) 491 (27.0%) 638 (23.6%)
Unknown 148 (16.7%) 92 (5.1%) 240 (8.9%)
Clinical 1: Very fit 94 (10.6%) 102 (5.6%) 196 (7.3%)  < 0.001
Frailty 2: Fit 119 (13.5%) 173 (9.5%) 292 (10.8%)
Score (CFS) 3: Managing well 217 (24.5%) 685 (37.7%) 902 (33.4%)
4: Vulnerable 93 (10.5%) 234 (12.9%) 327 (12.1%)
5: Mildly frail 82 (9.3%) 184 (10.1%) 266 (9.8%)
6: Moderately frail 114 (12.9%) 241 (13.3%) 355 (13.1%)
7–9: Severely frail 164 (18.6%) 197 (10.8%) 361 (13.4%)
Missing 1 (0.1%) 1 (0.1%) 2 (0.1%)
Charlson 0 90 (10.2%) 207 (11.4%) 297 (11.0%) 0.232
Comorbidity 1 82 (9.3%) 209 (11.5%) 291 (10.8%)
Index (CCI) 2 112 (12.7%) 227 (12.5%) 339 (12.6%)
3 102 (11.5%) 248 (13.6%) 350 (13.0%)
4 132 (14.9%) 237 (13.0%) 369 (13.7%)
5 127 (14.4%) 222 (12.2%) 349 (12.9%)
6 104 (11.8%) 194 (10.7%) 298 (11.0%)
7 59 (6.7%) 130 (7.2%) 189 (7.0%)
8_over 76 (8.6%) 143 (7.9%) 219 (8.1%)
BMI  < 18.5 49 (5.5%) 80 (4.4%) 129 (4.8%)  < 0.001
Grouped 18.5–24.9 258 (29.2%) 527 (29.0%) 785 (29.1%)
(kg/m2) 25–29.9 230 (26.0%) 559 (30.8%) 789 (29.2%)
 ≥ 30 206 (23.3%) 528 (29.1%) 734 (27.2%)
Missing 141 (16.0%) 123 (6.8%) 264 (9.8%)
Symptomatic at admission No 50 (5.7%) 361 (19.9%) 411 (15.2%)  < 0.001
Yes 834 (94.3%) 1456 (80.1%) 2290 (84.8%)

p value corresponds to the chi square test of independence